Statistics
Publications
7
Citations
370
H-Index
7
Active since
2014
Feng Yu is an author at The University of Adelaide specializing in molecular oncology, oncology, and cancer cell signaling.
Publications per year
2014–2019
7
7
p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA
Feng Yu, Cameron P. Bracken, Katherine A. Pillman et al. · PLoS ONE · 2015 · 109 citations · Full text
Naturally existing isoforms of miR-222 have distinct functions
Feng Yu, Katherine A. Pillman, Corine T. Neilsen et al. · Nucleic Acids Research · 2017 · 75 citations · Full text
MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7
Juntang Li, Lintao Jia, Ningning Liu et al. · Oncotarget · 2015 · 65 citations · Full text
Medicine, Cancer Biology, Oncology +17
Juntang Li, Lifeng Wang, Yali Zhao et al. · Breast Cancer Research · 2014 · 57 citations · Full text
Medicine, Cancer Biology, Oncology +17
Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway
Wenjie Zhang, Feng Yu, Yu Wang et al. · Oncology Letters · 2018 · 29 citations · Full text
Medicine, Cancer Biology, Oncology +16
1–5 of 7